Saturday, October 31, 2026

Nikola Stock Impressive Fall 13% So Far On Wednesday, Underperforms Market

Nikola Stock  Impressive Fall 13%  So Far On Wednesday, Underperforms Market

Nikola Corporation (NASDAQ:NKLA) shares experienced a drastic drop marking a consistent pattern of losses in recent trading sessions. This observed fall is amidst a general decline in market conditions with NASDAQ also showing a slight drop since yesterday's trading session.

Performance of tech firm

An Arizona based tech firm, Nikola Corp., renowned for its groundbreaking energy and transportation solutions saw a significant decline. It closed significantly low from its previous 52-week high. This tech firm primarily focuses on developing and selling both battery and hydrogen fuel cell electric vehicles (BEV and FCEV), in addition to offering fueling stations and reliable charging solutions.

Profitability Concerns

Despite Nikola's innovative solutions, the firm's profitability remains an area of concern. The Earnings Per Share (EPS) figure for Nikola during its trailing twelve-month earnings period was merely 1.4. Meanwhile, the Return On Equity percentage was negative 137.05%, demonstrating financial distress.

Overbought Stock

Additionally, the Nikola stock is currently classified as "overbought" as per the stochastic oscillator, a popular indicator for overbought and oversold conditions. Worryingly, the trading volume has also diminished drastically falling by 37.93% below its average, with the last reported volume being 50,146,479.

Growth Expectations

Despite the current slump, Nikola anticipates a resurgence in its growth, projecting a rise in the quarters to come. The firm predicts a growth rate of 12% this quarter, escalating to 35.7% for the next. Although sales growth currently stands at negative 14.9%, it is projected to reach 37.9% over time.

Investor Concerns

Nikola's stock price decline likely mirrors investors' burgeoning concerns regarding its profitability and the prevailing market conditions. There are reservations specifically about the sales and growth performance in the forthcoming quarters.

More news about Nikola (NKLA).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com